Chai Discovery
Develops AI models for molecular prediction and drug discovery.
aibiotech
Company facts
Series B-stage
- Founded
- 2024
- Employees
- 29
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $130M · 2025
Open positions
1 job


5 views 8 months ago
Business Development
Open 134d On-siteNorth America
United States
San Francisco officeAbout Chai Discovery Chai Discovery builds the computer-aided design suite for molecules. Eli Lilly, GSK, Pfizer, Bristol Myers Squibb, argenx and Novartis all use Chai to power drug discovery programs. AI is…